Patents Assigned to NANOSPHERE HEALTH SCIENCES, LLC
  • Patent number: 10596124
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: March 24, 2020
    Assignee: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • Patent number: 10028919
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: July 24, 2018
    Assignee: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • Patent number: 9925149
    Abstract: Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: March 27, 2018
    Assignee: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • Publication number: 20170000744
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Application
    Filed: June 4, 2015
    Publication date: January 5, 2017
    Applicant: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman